HI
CRSP icon

Harbour Investments’s CRISPR Therapeutics CRSP Stock Holding History

Harbour Investments’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Buy
3,489
+1,622
+87% +$85.5K ﹤0.01% 1632
2025
Q4 		$97.9K Sell
1,867
-7
-0.4% -$419 ﹤0.01% 1648
2025
Q3 		$121K Buy
1,874
+599
+47% +$34.4K ﹤0.01% 1493
2025
Q2 		$62K Sell
1,275
-136
-10% -$5.26K ﹤0.01% 1712
2025
Q1 		$48K Sell
1,411
-306
-18% -$13K ﹤0.01% 1791
2024
Q4 		$67.6K Sell
1,717
-350
-17% -$16.5K ﹤0.01% 1569
2024
Q3 		$97.1K Sell
2,067
-139
-6% -$7.05K ﹤0.01% 1330
2024
Q2 		$119K Buy
2,206
+389
+21% +$22.5K ﹤0.01% 1163
2024
Q1 		$124K Buy
1,817
+236
+15% +$16.9K ﹤0.01% 1114
2023
Q4 		$99K Sell
1,581
-114
-7% -$6.3K ﹤0.01% 1141
2023
Q3 		$76.9K Buy
1,695
+4
+0.2% +$207 ﹤0.01% 1146
2023
Q2 		$94.9K Buy
1,691
+60
+4% +$3.4K ﹤0.01% 1083
2023
Q1 		$73.8K Hold
1,631
– – ﹤0.01% 1182
2022
Q4 		$66.3K Sell
1,631
-61
-4% -$3.24K ﹤0.01% 1186
2022
Q3 		$103K Hold
1,692
– – 0.01% 949
2022
Q2 		$103K Buy
+1,692
New +$99.5K 0.01% 949
2021
Q4 		$113K Buy
1,491
+952
+177% +$83.2K 0.01% 922
2021
Q3 		$60K Buy
539
+54
+11% +$6.78K ﹤0.01% 1658
2021
Q2 		$79K Sell
485
-39
-7% -$4.74K ﹤0.01% 1526
2021
Q1 		$64K Buy
+524
New +$79.1K ﹤0.01% 1530

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbour Investments's CRSP Position: Q1 2026 in Review

Harbour Investments increased its CRISPR Therapeutics (CRSP) stake by 87% in Q1 2026, buying an estimated $85.5K and bringing the position to 3,489 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Harbour Investments first reported a position in CRSP in Q1 2021 and has held it in 20 quarters since. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Harbour Investments held 3,489 shares of CRISPR Therapeutics worth $166K as of Q1 2026.
  • Harbour Investments bought 1,622 CRISPR Therapeutics shares in Q1 2026, an estimated $85.5K.
  • CRISPR Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1632 holding.
  • Harbour Investments first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.